{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:48:01Z","timestamp":1787161681015,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd009493","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000}}],"reference-count":21,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009493.pub2","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T12:21:24Z","timestamp":1488284484000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["N-acetylcarnosine (NAC) drops for age-related cataract"],"prefix":"10.1002","volume":"2017","author":[{"given":"Vincent DJ-P","family":"Dubois","sequence":"first","affiliation":[{"name":"Aintree University Hospital NHS Foundation Trust; Elective Care Centre; Longmore Lane Liverpool UK L9 7AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bastawrous","sequence":"additional","affiliation":[{"name":"Mersey Deanery; Liverpool UK"},{"name":"London School of Hygiene & Tropical Medicine; International Centre for Eye Health; Keppel Street London UK WC1E 7HT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD009493.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MJT.0b013e318195e327","article-title":"N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients","volume":"16","author":"Babizhayev","year":"2009","journal-title":"American Journal of Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD009493.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cbf.1737","article-title":"Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease","volume":"29","author":"Babizhayev","year":"2011","journal-title":"Cell Biochemistry and Function"},{"issue":"2","key":"10.1002\/14651858.CD009493.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00126839-200203020-00004","article-title":"Efficacy of N-acetylcarnosine in the treatment of cataracts","volume":"3","author":"Babizhayev","year":"2002","journal-title":"Drugs in R&D"},{"issue":"3","key":"10.1002\/14651858.CD009493.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/rej.2004.7.186","article-title":"Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops","volume":"7","author":"Babizhayev","year":"2004","journal-title":"Rejuvenation Research"},{"issue":"7454","key":"10.1002\/14651858.CD009493.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD009493.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0005-2760(89)90085-4","article-title":"Antioxidant activity of L-carnosine, a natural histidine-containing dipeptide in the crystalline lens","volume":"1004","author":"Babizhayev","year":"1989","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1002\/14651858.CD009493.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(96)06356-5","article-title":"N alpha-acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant","volume":"254","author":"Babizhayev","year":"1996","journal-title":"Clinica Chemica Acta"},{"issue":"3","key":"10.1002\/14651858.CD009493.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1751-1097.1988.tb02737.x","article-title":"Some prevalent biomolecules as defenses against singlet oxygen damage","volume":"47","author":"Dahl","year":"1988","journal-title":"Photochemistry and Photobiology"},{"issue":"2","key":"10.1002\/14651858.CD009493.pub2-BIB0009|cit9","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD009493.pub2-BIB0010|cit10","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"key":"10.1002\/14651858.CD009493.pub2-BIB0011|cit11","unstructured":"Higgins JP Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009493.pub2-BIB0012|cit12","unstructured":"Health and Social Care Information Centre Hospital Episode Statistics digital.nhs.uk\/hes"},{"issue":"4","key":"10.1002\/14651858.CD009493.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0161-6420(99)00184-0","article-title":"Initial two years of experience with the AAO National Eyecare Outcomes Network (NEON) cataract surgery database","volume":"107","author":"Lum","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD009493.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD009493.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0886-3350(01)01269-X","article-title":"Prophylactic intracameral cefuroxime - efficacy in preventing endophthalmitis after cataract surgery","volume":"28","author":"Montan","year":"2002","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"11","key":"10.1002\/14651858.CD009493.pub2-BIB0016|cit16","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD009493.pub2-BIB0017|cit17","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD009493.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/09286586.2012.698692","article-title":"Cataract Surgery among Medicare Beneficiaries","volume":"19","author":"Schein","year":"2012","journal-title":"Ophthalmic Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD009493.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archopht.1994.01090170074026","article-title":"The VF-14: An index of functional impairment in patients with cataract","volume":"112","author":"Steinberg","year":"1994","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD009493.pub2-BIB0020|cit20","unstructured":"Sterne JAC Egger M Moher D editor(s) Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Intervention Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"12","key":"10.1002\/14651858.CD009493.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009493","article-title":"N-acetylcarnosine (NAC) drops for age-related cataract","author":"Dubois","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009493.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:34:03Z","timestamp":1784194443000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009493.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009493.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}